4 enrolling by invitation. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Enrolling by invitation 4 |
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Neurodevelopmental Disorders: new trials by email Literature Review of Neurodevelopmental Disorders trials Research Report on Neurodevelopmental Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Interventions Targeting These Pathways With cSVF, Stored MSCs, FMT and Diet Modification. Role of Autoimmunity, Gut-brain Issues, & Issues Examined. Autologous MSC isolation, concentration, and cryopreservation of adult mesenchymal stem cells, Fecal Biomicrome Transplantation (FMT), Ketogenic RESET Diet Protocol - Autism Spectrum Disorder, Autism | Phase 1 / Phase 2 | Enrolling by invitation | Black Tie Medical, Inc. | 50 | 2026-04-30 | 2026-04-27 |
| Neuroimaging of Escitalopram in Autism Spectrum Disorder Escitalopram 10mg, Placebo - Autism Spectrum Disorder | Phase 2 | Enrolling by invitation | Kathryn Unruh | 5 | 2025-04-28 | 2026-02-18 |
| Extending the Reach of Evidence-based Practices to Support Student's Attention and Behavior Through Technology Collaborative Life Skills dHealth tool (CLS-D) - Control Condition, Intervention Condition | Phase 2 | Enrolling by invitation | San Diego State University | 216 | 2024-09-01 | 2026-04-08 |
| Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label N-acetylcysteine - Autism Spectrum Disorder | Phase 2 / Phase 3 | Enrolling by invitation | Stanford University | 144 | 2024-03-12 | 2026-05-15 |
Autism Spectrum Disorder (3) · Attention Deficit Disorder with Hyperactivity (1) · Autistic Disorder (1) · Communication (1) · Intestinal Diseases (1) · Learning Disabilities (1)
Mental Disorders (4) · Child Development Disorders, Pervasive (3) · Attention Deficit and Disruptive Behavior Disorders (1) · Behavior (1) · Communication Disorders (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Acetylcysteine (1) · Anti-Inflammatory Agents (1) · Escitalopram (1) · Fecal Microbiota Transplantation (1) · Immunomodulation (1)
Black Tie Medical, Inc. (1) · Kathryn Unruh (1) · San Diego State University (1) · Stanford University (1)
United States (4)
John Hegarty, PhD (1) · Kathryn E Unruh, PhD (1) · Linda Pfiffner, PhD (1) · Miguel Villodas, PhD (1)
K99HD101702 (1)